TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33573276

Group type: EXPERIMENTAL
Intervention: Single doses of Pera orange juice
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single doses of Moro orange juice
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Profile B individuals (stratified group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stratification based on metabolic profiles
Number of subjects: 0
Study: 32539157

Group type: EXPERIMENTAL
Intervention: Brief intervention plus referral to treatment
Number of subjects: 126

Group type: COMPARATOR
Intervention: Referral to treatment only
Number of subjects: 126
Study: 36347056

Group type: EXPERIMENTAL
Intervention: Integrase strand transfer inhibitor therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single high-dose liposomal amphotericin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cryptococcal antigen lateral flow assay
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Systemic inflammation, astrocyte activation, and tryptophan metabolism pathways
Number of subjects: 0
Study: 34850013

Group type: EXPERIMENTAL
Intervention: Genetically predicted resting heart rate (10 beat/min higher)
Number of subjects: 878663

Group type: COMPARATOR
Intervention: Higher genetically predicted systolic blood pressure (SBP), TG, glucose, and WHR
Number of subjects: 878663

Group type: COMPARATOR
Intervention: Lower high-density lipoprotein
Number of subjects: 878663
Study: 32015185

Group type: EXPERIMENTAL
Intervention: P6 acupressure
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: LI4 acupressure
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control (thumb pad pressure)
Number of subjects: 120
Study: 34489282

Group type: EXPERIMENTAL
Intervention: Enhanced informed consent (experimental arm) - includes full length trial PIS, a two-page study aid, and 10 online educational videos.
Number of subjects: 34

Group type: COMPARATOR
Intervention: Standard informed consent (control arm) - includes full length trial PIS and administration of QuIC-A and QuIC-B.
Number of subjects: 34
Study: 33303437

Group type: EXPERIMENTAL
Intervention: Paracetamol
Number of subjects: 3922

Group type: COMPARATOR
Intervention: Ibuprofen
Number of subjects: 3922
Study: 35269639

Group type: EXPERIMENTAL
Intervention: 200 mg daily gluten intake
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34231257

Group type: EXPERIMENTAL
Intervention: Psoas muscle area (PMA) measurement before liver transplantation (LT)
Number of subjects: 276
Study: 32215562

Group type: EXPERIMENTAL
Intervention: 10-week outreach rehabilitation program
Number of subjects: 77

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 77
Study: 33939730

Group type: EXPERIMENTAL
Intervention: Ischemic preconditioning (IPC) - 3 X 5 min at 50 mmHg above systolic blood pressure
Number of subjects: 9

Group type: COMPARATOR
Intervention: SHAM intervention - same as IPC but at 20 mmHg
Number of subjects: 9
Study: 33183258

Group type: EXPERIMENTAL
Intervention: Intravenous TXA (1.0 g by intravenous injection before tourniquet inflation and before surgical incision closure)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topical TXA (3.0 g in 75 mL physiological saline 5 min prior to final tourniquet release)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (physiological saline solution)
Number of subjects: 0
Study: 35878827

Group type: EXPERIMENTAL
Intervention: Mothers and Babies 1‐on‐1 delivered by lay home visitors
Number of subjects: 1229

Group type: COMPARATOR
Intervention: Usual home visiting services
Number of subjects: 1229
Study: 33830339

Group type: EXPERIMENTAL
Intervention: TT + CTG
Number of subjects: 40

Group type: COMPARATOR
Intervention: TT + CGF
Number of subjects: 40
Study: 35925043

Group type: EXPERIMENTAL
Intervention: Pembrolizumab in combination with chemotherapy for neoadjuvant treatment and then as a single agent for adjuvant treatment.
Number of subjects: 123

Group type: COMPARATOR
Intervention: Placebo in combination with chemotherapy for neoadjuvant treatment and then as a single agent for adjuvant treatment.
Number of subjects: 123
Study: 33069214

Group type: EXPERIMENTAL
Intervention: Galcanezumab 120 mg once-monthly subcutaneous injection
Number of subjects: 722

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 722
Study: 35384714

Group type: EXPERIMENTAL
Intervention: Breast milk olfactory stimulation (30 seconds before heel stick)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (heel stick without olfactory stimulation)
Number of subjects: 48
Study: 33349135

Group type: EXPERIMENTAL
Intervention: AirSeal
Number of subjects: 100

Group type: COMPARATOR
Intervention: CIS
Number of subjects: 100
Study: 32139488

Group type: EXPERIMENTAL
Intervention: Oral felodipine in patients with coeliac disease (Group A, B+C, D)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Oral felodipine with grapefruit juice in healthy individuals
Number of subjects: 115

Group type: COMPARATOR
Intervention: Oral felodipine with water in healthy individuals
Number of subjects: 115
Study: 34251506

Group type: EXPERIMENTAL
Intervention: Lopinavir-ritonavir
Number of subjects: 694

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine
Number of subjects: 694

Group type: EXPERIMENTAL
Intervention: Combination therapy (lopinavir-ritonavir and hydroxychloroquine)
Number of subjects: 694

Group type: COMPARATOR
Intervention: Control (no antiviral therapy)
Number of subjects: 694
Study: 35083335

Group type: EXPERIMENTAL
Intervention: High-Intensive Interval Training (HIIT)
Number of subjects: 122
Study: 33157077

Group type: EXPERIMENTAL
Intervention: Adalimumab 40 mg subcutaneously every other week
Number of subjects: 364
Study: 2006134578

Group type: EXPERIMENTAL
Intervention: Anisodamine 0.5 mg/(kg24 h) intravenously for 7 days
Number of subjects: 38

Group type: COMPARATOR
Intervention: Common method (control group)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 38
Study: 35339911

Group type: EXPERIMENTAL
Intervention: Bright light therapy (BLT) 10,000 lux
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (<500 lux)
Number of subjects: 30
Study: 33241267

Group type: EXPERIMENTAL
Intervention: Sequential anti-tubercular treatment (ATT) regimen
Number of subjects: 97
Study: 32911505

Group type: EXPERIMENTAL
Intervention: Increased perceived intrinsic cost of lying (treatment condition)
Number of subjects: 225

Group type: COMPARATOR
Intervention: Standard condition (control)
Number of subjects: 225
Study: 35914303

Group type: COMPARATOR
Intervention: 0.05% cyclosporine eye drops (C group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Artificial tears (S group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Combination of 0.05% cyclosporine and artificial tears (CS group)
Number of subjects: 60
Study: 33721454

Group type: EXPERIMENTAL
Intervention: NIPS (oral S‐1 + intravenous and intraperitoneal chemotherapy with paclitaxel)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control (oral S‐1 + intravenous chemotherapy with oxaliplatin)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: NIPS (after chemotherapy)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: NIPS and Control (postoperative complications)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: NIPS and Control (follow-up)
Number of subjects: 80
Study: 33565403

Group type: EXPERIMENTAL
Intervention: Model group (n = 1,074)
Number of subjects: 1326

Group type: COMPARATOR
Intervention: Verification group (n = 252)
Number of subjects: 1326
Study: 32086925

Group type: EXPERIMENTAL
Intervention: Carbon nanoparticles suspension injected into the thyroid gland of trial group patients.
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Total thyroidectomy plus bilateral central neck dissection in trial group.
Number of subjects: 64

Group type: COMPARATOR
Intervention: Total thyroidectomy plus bilateral central neck dissection in control group.
Number of subjects: 64

Group type: COMPARATOR
Intervention: Trial group vs Control group for lymph nodes in black-stained tissue.
Number of subjects: 64

Group type: COMPARATOR
Intervention: Trial group vs Control group for mis-cut parathyroid glands.
Number of subjects: 64

Group type: COMPARATOR
Intervention: Trial group vs Control group for temporary hypocalcemia.
Number of subjects: 64

Group type: COMPARATOR
Intervention: Trial group vs Control group for temporary PTH decrease.
Number of subjects: 64
Study: 34233779

Group type: EXPERIMENTAL
Intervention: EMPOWER intervention (cognitive-behavioral, acceptance-based), 6 modules totaling 1.5-2 hours.
Number of subjects: 15
Study: 32741216

Group type: EXPERIMENTAL
Intervention: Circulating serum exosomal miR-20b-5p
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Circulating serum exosomal miR-3187-5p
Number of subjects: 0
Study: 36322270

Group type: EXPERIMENTAL
Intervention: FIND intervention
Number of subjects: 91

Group type: COMPARATOR
Intervention: Active control
Number of subjects: 91
Study: 33276225

Group type: EXPERIMENTAL
Intervention: Combined (neck stabilization exercises + motor imagery training)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Neck stabilization exercises alone
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 72
Study: 36347535

Group type: EXPERIMENTAL
Intervention: High-efficiency (tiered) OR
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional OR
Number of subjects: 0
Study: 32593895

Group type: EXPERIMENTAL
Intervention: HMB-enriched formula (calcium-HMB 1500 mg, L-arginine 7000 mg, L-glutamine 7000 mg per pack, 2 packs per day)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (no HMB-enriched formula)
Number of subjects: 33
Study: 34353714

Group type: EXPERIMENTAL
Intervention: Riociguat
Number of subjects: 579

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 579
Study: 32476468

Group type: EXPERIMENTAL
Intervention: Objective indices of estimated degree of relative decline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Subjective measures (Neurobehavioral Symptom Inventory, Personality Assessment Inventory)
Number of subjects: 0
Study: 33319565

Group type: EXPERIMENTAL
Intervention: SMOFlipid®
Number of subjects: 73
Study: 32171323

Group type: EXPERIMENTAL
Intervention: SGQR formula and buspirone placebo
Number of subjects: 200

Group type: COMPARATOR
Intervention: Buspirone and SGQR placebo
Number of subjects: 200
Study: 33499843

Group type: EXPERIMENTAL
Intervention: 4DryField® PH (5 g, subfascially and subcutaneously during wound closure)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 40
Study: 36065678

Group type: EXPERIMENTAL
Intervention: Fractional CO2 laser therapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Carboxytherapy
Number of subjects: 30
Study: 33038944

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 1800

Group type: EXPERIMENTAL
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 1800
Study: 34789504

Group type: EXPERIMENTAL
Intervention: Hybrid closed-loop (HCL) insulin delivery during high-intensity exercise (HIE)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Hybrid closed-loop (HCL) insulin delivery during moderate-intensity exercise (MIE)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Hybrid closed-loop (HCL) insulin delivery during resistance exercise (RE)
Number of subjects: 30
Study: 33746986

Group type: EXPERIMENTAL
Intervention: Probiotics (Lacticaseibacillus rhamnosus GG and Bifidobacterium animalis subsp. lactis, BB-12)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 32928851

Group type: EXPERIMENTAL
Intervention: Rhythm and Movement for Self-Regulation (RAMSR) intervention delivered by trained teachers during group time in kindergartens, daily for 8 weeks.
Number of subjects: 237

Group type: COMPARATOR
Intervention: Usual practice kindergarten programme (Control).
Number of subjects: 237
Study: 34990037

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2649
Study: 34217600

Group type: EXPERIMENTAL
Intervention: 20 Hz-rTMS
Number of subjects: 46

Group type: COMPARATOR
Intervention: iTBS
Number of subjects: 46
Study: 34498352

Group type: EXPERIMENTAL
Intervention: 12-week multimodal exercise-based program including supervised exercise twice weekly, protein supplement, home-based walking program, nurse-led support and counseling
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: 12-week multimodal exercise-based program
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 84
Study: 34467810

Group type: EXPERIMENTAL
Intervention: Interprofessional education session (working together interprofessionally)
Number of subjects: 225

Group type: COMPARATOR
Intervention: Control group (working together with their own profession)
Number of subjects: 225
Study: 32275482

Group type: EXPERIMENTAL
Intervention: Room temperature
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: 4 °C
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: ‐80 °C
Number of subjects: 95

Group type: COMPARATOR
Intervention: Storage temperature
Number of subjects: 95
Study: 33555314

Group type: EXPERIMENTAL
Intervention: Rapid-tapering regimen (immediate high-dose daily administration of prednisone, 0.75 mg/kg, followed by rapid decrease)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Slow-tapering regimen (gradual increase to 1.5 mg/kg every other day and slow decrease)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Rapid-tapering regimen
Number of subjects: 117

Group type: COMPARATOR
Intervention: Slow-tapering regimen
Number of subjects: 117
Study: 34346729

Group type: EXPERIMENTAL
Intervention: NIATx1 (active implementation strategy)
Number of subjects: 49

Group type: COMPARATOR
Intervention: NIATx2 (waitlist control)
Number of subjects: 49
Study: 34112615

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 2555

Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 2555

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery in KRAS/BRAF WT sub-group
Number of subjects: 2555

Group type: COMPARATOR
Intervention: Open surgery in KRAS/BRAF WT sub-group
Number of subjects: 2555
Study: 32311455

Group type: EXPERIMENTAL
Intervention: Paracetamol (aqueous solution or suspension)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Danazol (aqueous suspension)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Long-chain triglyceride solution of danazol
Number of subjects: 8
Study: 36189651

Group type: EXPERIMENTAL
Intervention: Polynucleotide and hyaluronic acid-based gel
Number of subjects: 50
Study: 33976420

Group type: EXPERIMENTAL
Intervention: Clinical genome sequencing (cGS)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Standard-of-care genetic testing (SOC)
Number of subjects: 204
Study: 34479364

Group type: EXPERIMENTAL
Intervention: Direct oral anticoagulants (DOACs) such as apixaban, edoxaban, and rivaroxaban
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low-molecular-weight heparins (LMWHs) such as dalteparin
Number of subjects: 0
Study: 33901518

Group type: EXPERIMENTAL
Intervention: Higher gestational age (per week)
Number of subjects: 421

Group type: EXPERIMENTAL
Intervention: Higher birthweight (per 100 grams)
Number of subjects: 421

Group type: EXPERIMENTAL
Intervention: Higher birthweight for gestational age z-score (per SD)
Number of subjects: 421

Group type: EXPERIMENTAL
Intervention: Birthweight and birthweight for gestational age z-score
Number of subjects: 421

Group type: EXPERIMENTAL
Intervention: Low birthweight (<2500 g)
Number of subjects: 421
Study: 37331522

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 172

Group type: COMPARATOR
Intervention: Insulin
Number of subjects: 172
Study: 33657912

Group type: EXPERIMENTAL
Intervention: Information Prescription (IP) prescribed by the physician plus routine oral information
Number of subjects: 120

Group type: COMPARATOR
Intervention: Routine oral information by nurse or physician (control group)
Number of subjects: 120
Study: 32351061

Group type: EXPERIMENTAL
Intervention: Phlogenzym (systemic enzyme therapy)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard antibiotic therapy
Number of subjects: 60
Study: 33783102

Group type: EXPERIMENTAL
Intervention: Negative-pressure wound therapy with instillation (NPWTi)
Number of subjects: 20
Study: 33646807

Group type: EXPERIMENTAL
Intervention: UP + SSRI (n = 18)
Number of subjects: 39

Group type: COMPARATOR
Intervention: continued SSRI‐only (n = 21)
Number of subjects: 39
Study: 33751054

Group type: EXPERIMENTAL
Intervention: QT3 (2.13% CT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: QT (0%, 1%, 2%, 3% CT)
Number of subjects: 20
Study: 32593287

Group type: EXPERIMENTAL
Intervention: HFNC with oxygen flow rate at 40 L/min
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: HFNC with oxygen flow rate at 60 L/min
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: HFNC with oxygen flow rate at 40 L/min or 60 L/min
Number of subjects: 65

Group type: COMPARATOR
Intervention: NPA
Number of subjects: 65
Study: 33556170

Group type: EXPERIMENTAL
Intervention: Computed tomography staging
Number of subjects: 149

Group type: COMPARATOR
Intervention: Institutional computed tomography staging
Number of subjects: 149
Study: 32132317

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Propofol (PROP)
Number of subjects: 196
Study: 35896153

Group type: EXPERIMENTAL
Intervention: Brief psychotherapy
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Immature defenses assessment at baseline
Number of subjects: 177
Study: 34110393

Group type: EXPERIMENTAL
Intervention: Child protection system notification(s) only
Number of subjects: 1635

Group type: EXPERIMENTAL
Intervention: Investigation(s) (not substantiated)
Number of subjects: 1635

Group type: EXPERIMENTAL
Intervention: Substantiated maltreatment
Number of subjects: 1635

Group type: EXPERIMENTAL
Intervention: Ever placed in out‐of‐home care
Number of subjects: 1635

Group type: COMPARATOR
Intervention: No child protection system contact (Control)
Number of subjects: 1635
Study: 33189606

Group type: EXPERIMENTAL
Intervention: Serum leucine levels
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Serum isoleucine levels
Number of subjects: 0
Study: 35227402

Group type: EXPERIMENTAL
Intervention: Written Exposure Therapy (WET)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Cognitive Processing Therapy (CPT)
Number of subjects: 126
Study: 35982520

Group type: EXPERIMENTAL
Intervention: Spatial training (reaching toward sound sources)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Nonspatial control training (identifying sound amplitude modulations)
Number of subjects: 20
Study: 34303267

Group type: COMPARATOR
Intervention: mFOLFOX (control arm)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: mFOLFIRI (experimental arm)
Number of subjects: 120
Study: 34348343

Group type: EXPERIMENTAL
Intervention: Chitosan nanoparticle and gum (CN-G) applied twice daily for 4 weeks
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (gum alone) applied twice daily for 4 weeks
Number of subjects: 24
Study: 33099083

Group type: EXPERIMENTAL
Intervention: Increased sense of witnessing agency (Self)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Decreased sense of witnessing agency (Self)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increased sense of body representational-emotional agency (Me)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Decreased sense of body representational-emotional agency (Me)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increased sense of reflective/narrative agency (I)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Decreased sense of reflective/narrative agency (I)
Number of subjects: 0
Study: 35583555

Group type: EXPERIMENTAL
Intervention: Venetoclax (800 mg orally daily) plus Fulvestrant (500 mg intramuscular; cycle 1: days 1 and 15; subsequent 28-day cycles: day 1)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Fulvestrant alone
Number of subjects: 103
Study: 33682320

Group type: EXPERIMENTAL
Intervention: 177 Lu-PSMA-617 followed by docetaxel
Number of subjects: 140

Group type: COMPARATOR
Intervention: Docetaxel
Number of subjects: 140
Study: 32168393

Group type: EXPERIMENTAL
Intervention: Health education interventions targeting healthcare providers or individuals, or both.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Health education interventions
Number of subjects: 0
Study: 35869437

Group type: EXPERIMENTAL
Intervention: Synbiotics (Lactobacillus acidophilus and Bifidobacterium longum 5x10^9 CFU)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 34499396

Group type: EXPERIMENTAL
Intervention: Hybrid comprehensive telerehabilitation (HCTR)
Number of subjects: 386
Study: 33051226

Group type: EXPERIMENTAL
Intervention: Small fenestration with clipping (eight metal clips around the peritoneal window)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Small fenestration alone (control arm)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Small fenestration with clipping
Number of subjects: 0
Study: 34937507

Group type: EXPERIMENTAL
Intervention: Vitamin D deficiency (25(OH)D < 10 ng/ml)
Number of subjects: 88
Study: 32964526

Group type: EXPERIMENTAL
Intervention: Breastfeeding interventions
Number of subjects: 0
Study: 36007881

Group type: EXPERIMENTAL
Intervention: Creatine Monohydrate (5 g/day)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Creatyl-L-Leucine (5 g/day)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 34182952

Group type: EXPERIMENTAL
Intervention: Brigatinib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Other approved second-generation ALK TKI
Number of subjects: 0
Study: 35636733

Group type: EXPERIMENTAL
Intervention: 150 min of aerobic exercise only
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: progressive resistance training only
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: combined aerobic and progressive resistance training
Number of subjects: 280

Group type: COMPARATOR
Intervention: flexibility/toning-control
Number of subjects: 280
Study: 32458647

Group type: COMPARATOR
Intervention: Cryotherapy (N=150)
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: Thermal Ablation (TA) (N=136)
Number of subjects: 286
Study: 35895568

Group type: EXPERIMENTAL
Intervention: Sporting males (sm)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Sporting females (sf)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Non-sporting males (nsm)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Non-sporting females (nsf)
Number of subjects: 200